[Pharmacological treatment of Rett syndrome improves breathing and survival in a mouse model].

Authors :: Roux JC
Villard L
Source :: Medecine sciences : M/S [Med Sci (Paris)] 2007 Oct; Vol. 23 (10), pp. 805-7.
Publication Year :: 2007

Subjects :: Adrenergic Uptake Inhibitors pharmacology
Animals
Brain Stem pathology
Brain Stem physiopathology
Cells, Cultured drug effects
Cells, Cultured metabolism
Desipramine pharmacology
Drug Evaluation, Preclinical
Female
Humans
Methyl-CpG-Binding Protein 2 deficiency
Methyl-CpG-Binding Protein 2 genetics
Methyl-CpG-Binding Protein 2 physiology
Mice
Mice, Knockout
Nerve Tissue Proteins deficiency
Neurons enzymology
Neurons pathology
Norepinephrine deficiency
Norepinephrine physiology
Respiration Disorders etiology
Rett Syndrome complications
Rett Syndrome genetics
Rett Syndrome physiopathology
Synaptic Vesicles drug effects
Synaptic Vesicles metabolism
Tyrosine 3-Monooxygenase deficiency
Adrenergic Uptake Inhibitors therapeutic use
Desipramine therapeutic use
Respiration Disorders drug therapy
Rett Syndrome drug therapy

Full Text Access

Tools